These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis. Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin-secreting cells in cord blood: effects of Epstein-Barr virus and interleukin-4. Gudmundsson KO; Thorsteinsson L; Gudmundsson S; Haraldsson A Scand J Immunol; 1999 Jul; 50(1):21-4. PubMed ID: 10404047 [TBL] [Abstract][Full Text] [Related]
8. Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen. MartÃnez-Maza O; Britton S J Exp Med; 1983 Jun; 157(6):1808-14. PubMed ID: 6304226 [TBL] [Abstract][Full Text] [Related]
9. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus. Conley ME; Chan MA; Sigal NH J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of EBV-transformable human B lymphocyte populations. Chan MA; Stein LD; Dosch HM; Sigal NH J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease. Nagata K; Kumata K; Nakayama Y; Satoh Y; Sugihara H; Hara S; Matsushita M; Kuwamoto S; Kato M; Murakami I; Hayashi K Viral Immunol; 2017 Apr; 30(3):240-249. PubMed ID: 28333576 [TBL] [Abstract][Full Text] [Related]
12. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells. Hibi T; Chan MA; Petsche D; Dosch HM J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613 [TBL] [Abstract][Full Text] [Related]
13. The B cell repertoire in rheumatoid arthritis. I. Frequency of EBV-inducible circulating precursors producing autoantibodies. Moynier M; Abderrazik M; Rucheton M; Combe B; Sany J; Brochier J J Autoimmun; 1991 Aug; 4(4):631-49. PubMed ID: 1663752 [TBL] [Abstract][Full Text] [Related]
14. T-cell-mediated suppression of Epstein-Barr virus-induced B lymphocyte activation in multiple sclerosis. Craig JC; Haire M; Merrett JD Clin Immunol Immunopathol; 1988 Sep; 48(3):253-60. PubMed ID: 2841052 [TBL] [Abstract][Full Text] [Related]
15. Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells. Bende RJ; Jochems GJ; Frame TH; Klein MR; van Eijk RV; van Lier RA; Zeijlemaker WP Cell Immunol; 1992 Sep; 143(2):310-23. PubMed ID: 1324802 [TBL] [Abstract][Full Text] [Related]
16. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution. Miyawaki T; Kubagawa H; Butler JL; Cooper MD J Immunol; 1988 Jun; 140(11):3887-92. PubMed ID: 2836502 [TBL] [Abstract][Full Text] [Related]
17. Limiting dilution analysis of the B cell compartment in human bone marrow. Hibi T; Dosch HM Eur J Immunol; 1986 Feb; 16(2):139-45. PubMed ID: 2869953 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus. Brown NA; Miller G J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-induced IgE production in limiting dilution cultures of normal human B cells. Stein LD; Chan MA; Hibi T; Dosch HM Eur J Immunol; 1986 Sep; 16(9):1167-70. PubMed ID: 3019708 [TBL] [Abstract][Full Text] [Related]
20. [Induction of IgG and IgM production by Epstein-Barr virus protein]. Zhang YG; Fu M; Liu YF; Gao TW; Pan L; Wang L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):103-4. PubMed ID: 15132924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]